Table 1.
Characteristics of women enrolled in the TRIO study (2015–2017), and the sub-sample of women selected to participant in a qualitative activity, by country
| Qualitative sub-sample | TRIO study sample | |||||||
|---|---|---|---|---|---|---|---|---|
| Soshanguve, South Africa | Kisumu, Kenya | Total | ||||||
| Characteristic | N = 45 | N = 43 | N = 88 | N = 277 | ||||
| N | (%) | N | (%) | N | (%) | N | (%) | |
| Age, years | ||||||||
| Median (Interquartile range) | 24 | (18–30) | 23 | (18–29) | 23 | (18–30) | 23 | (21–26) |
| 18–24 | 28 | (62) | 29 | (67) | 57 | (65) | 183 | (66) |
| 25–30 | 17 | (38) | 14 | (33) | 35 | (35) | 94 | (34) |
| Currently have a primary partner | 44 | (98) | 40 | (93) | 84 | (96) | 261 | (94) |
| Married or cohabiting | 1 | (2) | 20 | (47) | 21 | (24) | 79 | (29) |
| Currently have a casual sex partner | 5 | (11) | 12 | (28) | 17 | (19) | 50 | (18) |
| Exchange sex ever | 2 | (4) | 10 | (23) | 12 | (14) | 33 | (12) |
| Parity > 0 | 33 | (73) | 31 | (72) | 64 | (73) | 216 | (78) |
| Completed secondary school | 29 | (64) | 18 | (42) | 47 | (53) | 143 | (52) |
| Earns an income | 8 | (18) | 20 | (47) | 28 | (32) | 86 | (31) |
| Worried contract HIV in next 12 months | ||||||||
| Not at all/a little | 24 | (53) | 31 | (72) | 55 | (63) | 179 | (65) |
| Somewhat/very/extremely | 21 | (47) | 12 | (28) | 33 | (38) | 98 | (35) |
| Method(s) ever useda | ||||||||
| Male condom | 44 | (98) | 40 | (93) | 84 | (96) | 255 | (92) |
| Injectable | 37 | (82) | 24 | (56) | 61 | (69) | 194 | (70) |
| Implants | 11 | (24) | 17 | (40) | 28 | (32) | 98 | (35) |
| Pills | 11 | (24) | 13 | (30) | 24 | (27) | 72 | (26) |
| Intrauterine device | 5 | (11) | 2 | (5) | 7 | (8) | 14 | (5) |
| Female condom | 3 | (7) | 10 | (23) | 13 | (15) | 25 | (9) |
| Other | 1 | (2) | 2 | (5) | 3 | (3) | 10 | (4) |
| None | 0 | (0) | 1 | (2) | 1 | (1) | 2 | (1) |
| Method(s) used at enrollmenta,b | ||||||||
| Male condom | 29 | (64) | 24 | (56) | 53 | (60) | 141 | (51) |
| Injectable | 22 | (49) | 15 | (35) | 37 | (42) | 115 | (42) |
| Implants | 9 | (20) | 7 | (16) | 16 | (18) | 67 | (24) |
| Pills | 2 | (4) | 6 | (14) | 8 | (9) | 18 | (7) |
| Intrauterine device | 5 | (11) | 1 | (2) | 6 | (7) | 11 | (4) |
| Female condom | 0 | (0) | 4 | (9) | 4 | (5) | 8 | (3) |
| Other | 1 | (2) | 2 | (5) | 3 | (3) | 6 | (2) |
| None | 5 | (11) | 5 | (12) | 10 | (11) | 29 | (11) |
a
Can select more than one, total is more than 100%.
b
35% reported dual method use currently (condoms and another contraceptive method).